Rhamnazin (3,7-Dimethylquercetin) is an orally active VEGFR2 signaling inhibitor with anti-angiogenesis, anti-tumor, antioxidant, and anti-inflammatory activities. It inhibits VEGFR2 kinase and is used for leukemia research.
Molecular Weight:
330.29
CAS Number:
[552-54-5]
Formula:
C17H14O7
Target:
VEGFR
TN2150
TN2150
* VAT and and shipping costs not included. Errors and price changes excepted